CIM21SAPP2-12 is an early-maturing, white, high yielding, drought tolerant, NUE, and resistant to GLS, TLB and MSV, bred for food use in tropical, rainfed, dry/wet mid-altitude and lowland ecologies in southern Africa and similar agroecologies. |
|
General Information |
|
Target region |
Southern Africa |
|
Adaptation/Agroecological zone |
<1800 masl |
|
Type of product |
Three-way cross hybrid |
|
Year first announced |
2022 |
|
|
|
|
|
Grain Yield |
|
Grain Characteristics |
Grain yield under optimum conditions |
9.14 t/ha |
|
Grain color |
White |
Grain yield under managed drought stress |
3.41 t/ha |
|
Grain texture |
Semi dent |
Grain yield under low N stress |
5.95 t/ha |
|
|
|
|
|
|
Biotic Stress Performance |
Agronomic Characteristics |
|
Turcicum leaf blight (TLB) (1-9)* |
4.1 |
50% anthesis |
858 GDD (°C) |
|
Grey leaf spot (GLS) (1-9)* |
3.0 |
Anthesis-silking interval |
0.17 Days |
|
Maize Streak Virus (MSV) (1-9)* |
3.3 |
Plant height |
259.2 cm |
|
Ear rots |
5.7% |
Ear height |
137.9 cm |
|
*Diseases are scored on a 1-9 scale, where 1 = Highly resistant; 5 = Tolerant; 9 = Highly susceptible. |
Ears per plant |
1.1 |
|
Bad husk cover |
7.8% |
|
|
|
Ear aspect (1-5)* |
2.4 |
|
Seed Production Characteristics |
Root lodging |
3.5% |
|
SC female parent yield |
9.34 t/ha |
Stalk lodging |
2.9% |
|
Male parent yield |
3.13 t/ha |
*Ear aspect is scored on 1-5 scale, where 1 = desirable and 5 = undesirable characteristics |
|
Nicking |
-3.03 days |
|
|
|
|
|
|
Comments |
Further Links |
|
Product information is based on data from various trials conducted by CIMMYT in southern Africa in 2021 and 2022. Actual performance will vary depending on a number of agronomic and environmental factors.
Abbreviations:
GDD = growing degree-days
GLS = Grey Leaf Spot
Low N = managed low nitrogen stress
masl = meters above sea level
MSV = Maize Streak Virus
opt. = optimum (44,444 plants per ha)
SC = single-cross
TLB = Turcicum Leaf Blight (E. turcicum) |
Full product announcement, including southern Africa 2021 Regional Trial and 2022 Regional On-Farm Trial data |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|